|
31/07/2024
|
07:00
|
Launch of PTRA Assay using Verici Dx's technology
|
RNS
|
|
15/07/2024
|
07:00
|
Half-year Report
|
RNS
|
|
11/07/2024
|
14:00
|
Notice of Results and Business Update
|
RNS
|
|
01/07/2024
|
07:00
|
Significant milestone re Thermo Fisher agreement
|
RNS
|
|
25/06/2024
|
13:27
|
Result of AGM
|
RNS
|
|
18/06/2024
|
07:00
|
Transfer of urine samples to Thermo Fisher
|
RNS
|
|
31/05/2024
|
13:57
|
Notice of AGM and posting of Annual Report
|
RNS
|
|
30/05/2024
|
07:00
|
2023 Annual Results
|
RNS
|
|
27/02/2024
|
16:08
|
Holding(s) in Company
|
RNS
|
|
22/02/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
21/02/2024
|
16:53
|
Holding(s) in Company
|
RNS
|
|
21/02/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
19/02/2024
|
12:35
|
Result of General Meeting
|
RNS
|
|
14/02/2024
|
07:00
|
Result of Retail Offer
|
RNS
|
|
26/01/2024
|
12:32
|
Publication of Circular
|
RNS
|
|
25/01/2024
|
11:00
|
Launch of Retail Offer
|
RNS
|
|
24/01/2024
|
18:11
|
Result of Placing
|
RNS
|
|
24/01/2024
|
10:39
|
Close of Accelerated Bookbuild
|
RNS
|
|
24/01/2024
|
07:00
|
Proposed Fundraising
|
RNS
|
|
11/12/2023
|
07:00
|
Tutiviaâ„¢ validation study published in Journal
|
RNS
|
|
20/11/2023
|
07:00
|
Investor Presentation
|
RNS
|
|
15/11/2023
|
07:00
|
Commercialisation agreement with Thermo Fisher
|
RNS
|
|
29/09/2023
|
07:00
|
Half-year Report
|
RNS
|
|
06/07/2023
|
07:00
|
Investor Presentation
|
RNS
|
|
03/07/2023
|
07:00
|
Successful clinical validation of Clarava™
|
RNS
|
|
29/06/2023
|
16:57
|
Result of AGM
|
RNS
|
|
06/06/2023
|
07:00
|
Notice of AGM and posting of Annual Report
|
RNS
|
|
05/06/2023
|
07:01
|
2022 Annual Results
|
RNS
|
|
05/06/2023
|
07:00
|
Proposed US pricing for Tutivia™
|
RNS
|
|
31/05/2023
|
07:00
|
Notice of Results
|
RNS
|
|
24/05/2023
|
07:01
|
Update re. EKF distribution of shares in Verici Dx
|
RNS
|
|
24/05/2023
|
07:00
|
Distribution of shares in Verici Dx plc
|
RNS
|
|
28/03/2023
|
11:05
|
Second Price Monitoring Extn
|
RNS
|
|
28/03/2023
|
11:00
|
Price Monitoring Extension
|
RNS
|
|
28/03/2023
|
09:05
|
Second Price Monitoring Extn
|
RNS
|
|
28/03/2023
|
09:00
|
Price Monitoring Extension
|
RNS
|
|
27/03/2023
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
27/03/2023
|
11:05
|
Second Price Monitoring Extn
|
RNS
|
|
27/03/2023
|
11:00
|
Price Monitoring Extension
|
RNS
|
|
22/03/2023
|
07:00
|
Operational Update
|
RNS
|
|
21/03/2023
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
|
21/03/2023
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
13/03/2023
|
07:00
|
Statement re. Silicon Valley Bank
|
RNS
|
|
09/03/2023
|
07:00
|
Two key patents granted in the US
|
RNS
|
|
02/03/2023
|
07:00
|
CLIA Certificate of Compliance
|
RNS
|
|
27/02/2023
|
14:00
|
Price Monitoring Extension
|
RNS
|
|
07/12/2022
|
07:00
|
Director/PDMR Shareholding
|
RNS
|
|
01/12/2022
|
18:07
|
Correction: Holding(s) in Company
|
RNS
|
|
03/10/2022
|
07:00
|
Product rebranding as Tutivia™
|
RNS
|
|
07/09/2022
|
07:00
|
Half-year Report
|
RNS
|